Conditions: Asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 27
Healthy volunteers: no

Brief summary:
This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of multiple dose treatment with MK-1029 in adults with mild to moderate persistent asthma.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: MK-1029 intervention 2: Placebo for MK-1029
Intervention descriptions: intervention 1: Five (5) X 100 mg capsules, orally, once daily for 28 days intervention 2: Five (5) X 100 mg capsules, orally, once daily for 28 days

Protocol document: